Curated Video
"Magic Mushrooms" in smoke shops. What's in them?
“Magic Mushrooms” can be found in smoke shops and gas stations around the country. But what’s actually in them? It's not Psilocybin.
Curated Video
The nightmarish symptoms of fentanyl withdrawal
Mass General Brigham’s Sarah Wakeman details the terrible symptoms of fentanyl withdrawal More from STAT: Become a subscriber: https://www.statnews.com/stat-plus/ Watch Full Episodes: https://www.youtube.com/@Statnews Newsletters:...
Curated Video
H5N1 #birdflu has been found in a pig: What you need to know.
@statnews H5N1 #birdflu has been found in a pig: What you need to know. #health #science #publichealth #statnews #oregon
Curated Video
Bill Nye's family history with neurological disorder ataxia
Read a Q&A with Bill Nye at STAT: https://www.statnews.com/2024/10/10/bill-nye-science-guy-speaks-out-on-ataxia/ More from STAT: Become a subscriber: https://www.statnews.com/stat-plus/ Watch Full Episodes:...
Curated Video
New weight loss drugs causing too much weight loss?
STAT reporter Elaine Chen details how some clinical trial participants report losing too much weight, too quickly on Eli Lilly's next-generation GLP-1 drug, retatrutide. In trials, retatrutide has been shown to cause more weight loss...
Curated Video
Why is measles so contagious?
There is a measles outbreak in the US, with more than 100 cases across Texas and New Mexico. Here's a look at why it spreads so easily. More from STAT: Become a subscriber: https://www.statnews.com/stat-plus/ Watch Full Episodes:...
Bloomberg
Novo Owner Targets More China Biotech Deals
Novo Holdings CEO Kasim Kutay says China has "really moved up the value chain" in healthcare. "We've seen many others investing in China because of the leap that they're taking from an innovation and technology perspective," Kutay says...
Bloomberg
Illumina CEO Thaysen on Nvidia Partnership, Genomics, M&A
Illumina CEO Jacob Thaysen discusses the outlook for genomics and the company's partnership with Nvidia. He speaks with Katherine Greifeld at the JPMorgan Health-Care Conference in San Francisco.
Bloomberg
Biopharma's Tech Adoption Challenges
Life sciences-focused cloud startup Benchling has seen its business soar over the last few years, amid a renewed interest in biotech among investors. Benchling CEO Sajith Wickramasekara joins Caroline Hyde and Ed Ludlow to discuss the...
Bloomberg
Step in Right Direction: Rep. Moulton on China Investment Limit
Democratic Representative of Massachusetts, Seth Moulton, discusses President Biden's executive order imposing restrictions on China's ability to develop next-generation military and surveillance technologies that might threaten US...
Bloomberg
Merck and Sega Usher M&A Into Spring Renaissance
Liana Baker has more on Merck buying Prometheus for $10.8 billion in cash and Sega buying Rovio Entertainment in a deal that values the creator of Angry Birds at about 706 million ($776 million). She speaks on "Bloomberg Markets: The...
Press Association
Starmer visits biotech company in Edinburgh
Leader of the opposition, Sir Keir Starmer, visited the biotech company Roslin CT in Edinburgh on Thursday. Starmer said that innovation was being 'held back' by the Government in Westminster and the Scottish Government.
Bloomberg
MeiraGTx CEO on Potential of Gene Therapy, Innovation
Zandy Forbes, MeiraGTx chief executive officer, discusses the potential of gene therapy and harnessing the power of research at universities. She speaks with Bloomberg's Francine Lacqua on "Bloomberg Surveillance: Early Edition".
Bloomberg
Springhill Fund CIO on China Healthcare
Springhill Fund CIO Jane Wu explains why she believes China's healthcare sector is in a golden era of development and innovation. She speaks with Rishaad Salamat, Yvonne Man and David Ingles on "Bloomberg Markets Asia."
Bloomberg
The Ethical Implications of Gene-Edited Babies
Nov.29 -- Jiwoo Lee, a Stanford University student, and Bloomberg's Drew Armstrong discuss the researcher who shocked the world with claims that he was the first to genetically modify human embryos drew early support from Chinese...
Bloomberg
The Technology Behind Bluebird Bio
May.19 -- Bluebird Bio CEO Nick Leschly discusses gene therapy, Boston's biotech scene, and venture capital with Bloomberg's Caroline Hyde on "Bloomberg Technology" at the Museum of Science in Boston on May 9.
Bloomberg
The Brain Implant That Can Partially Reverse Paralysis
Jun.19 -- It sounds like science fiction: a device that can reconnect a paralyzed person’s brain to his or her body. But that’s exactly what the experimental NeuroLife system does. Developed by Battelle and Ohio State University,...
Bloomberg
Apeiron's Angermayer on Technology for Happiness
Christian Angermayer, Founder, Apeiron Investment Group spoke to Bloomberg's Devon Pendleton at the Bloomberg Technology Summit about his technology investments and how he thinks they will improve human lives.
Bloomberg
EverGrain, ZX Ventures Execs on Corporate Venturing
Greg Belt, Founder & CEO, EverGrain, and Bernardo Novick, Managing Partner & Head, ZX Ventures, share how they are working together to develop sustainable solutions in the food and beverage sector with Bloomberg's Meg Szabo.
Bloomberg
Illumina Benefiting From Increased Access to Tests: CEO
"We're seeing a lot of progress in the genomics market in terms of making tests more available," Illumina CEO Francis deSouza says. He speaks on "Bloomberg Markets: The Close."
Bloomberg
B Capital's Ganguly on SE Asia Investment Opportunities
Raj Ganguly, Co-founder and Partner at B Capital, discusses the investment opportunities in Southeast Asia and tech startups. He speaks with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia".
Bloomberg
Bill Gates on Biotech, Bioengineering, and Pharma
June 30 -- Billionaire Bill Gates discusses drug pricing, medical research, bioengineering, artificial intelligence, and biotech with Bloomberg's Erik Schatzker in Boston.
Bloomberg
10X Genomics CEO Sees a Lot of Growth Potential in Asia
Jan.07 -- Serge Saxonov, 10X Genomics chief executive officer, discusses the company's growth opportunities and the future of genome technology with Bloomberg's Taylor Riggs on "Bloomberg Technology."
Bloomberg
China's Everest Medicines Makes Hong Kong Trading Debut
Oct.08 -- Kerry Blanchard, chief executive officer of Chinese biotech firm Everest Medicines Ltd., talks about the company's initial public offering in Hong Kong and its growth strategy. Everest focuses on developing drugs already...